Integra LifeSciences Holdings recently reported first-quarter 2026 results, with adjusted earnings per share above analyst expectations and revenues increasing slightly year over year, and its CFO, ...

Over the past six months, Integra LifeSciences has been a great trade, beating the S&P 500 by 25.3%. Its stock price has ...

Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Richard Caruso, founder and former chairman and CEO of Princeton-based Integra LifeSciences, died Aug. 12 “after a long courageous battle with dementia,” according to his obituary. He was 79. Caruso ...

Stuart Essig Appointed as Integra’s Next President and Chief Executive OfficerMichael McBreen Appointed Chief Commercial OfficerPRINCETON, N.J., ...

Shares of Integra Lifesciences (NASDAQ: IART) were sinking 15.5% as of 11 a.m. ET on Monday. The decline came after the medical technology company announced its second-quarter results before the ...

Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2026. First Quarter 2026 ...

Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported first-quarter revenues of $368.9 million, down 3.1% Y/Y on a reported basis and 2.5% on an organic basis, beating the consensus ...

Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job.

Integra LifeSciences Holdings Corp. is seeking to establish itself in the ear, nose and throat category with its acquisition of Acclarent Inc. The Princeton-based medical technology company announced ...

Integra LifeSciences IART reported upbeat second-quarter earnings and lowered its FY24 guidance below estimates on Monday. Integra Lifesciences posted adjusted earnings of 63 cents per share, beating ...

Integra Lifesciences topped analysts' Q2 revenue and earnings estimates. However, the company reduced its full-year guidance. Integra's CEO said the medical technology company faces "operational ...